| 000 | 00833nam a22002412 4500 | ||
|---|---|---|---|
| 001 | hsl001006259 | ||
| 003 | DGPO | ||
| 005 | 20170826152550.0 | ||
| 008 | 170110s1974 dcu f000 0 eng d | ||
| 040 |
_aGPO _cGPO _dMvI |
||
| 086 | 0 |
_aHE 20.3161/A:C 989/3 _zHE 20.3161/A:C 999/2 |
|
| 099 | _aHE 20.3161/A:C 989/3 | ||
| 100 | 1 | _aLaux, David C. | |
| 245 | 1 | 0 |
_aEvaluation of factors contributing to tumor resistance to cyclophosphamide / _cby David C. Laux and Robert N. Lausch. |
| 260 |
_a[Washington, D.C., _c1974] |
||
| 300 |
_ap. 863-868 : _bill. |
||
| 500 | _a4to. | ||
| 500 | _aReprinted from Journal of National Cancer Institute, v.52, no.3, Mar. 1974. | ||
| 500 | _aCRDP Program Historic Shelflist record. | ||
| 650 | 0 |
_aCancer _xResearch. |
|
| 700 | 1 | _aLausch, Robert N. | |
| 710 | 2 | _aNational Cancer Institute (U.S.) | |
| 949 |
_aBEV _bFed Docs |
||
| 999 |
_c264291 _d264291 |
||